Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

Pre Market Movers
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Copy Top Investors Portfolio
Crypto Technical Analysis
Chart Pattern Signal

Resources

Blog
Earnings
Partner Program

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ABT
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
ABT
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

ABT Price Prediction Next Week

Based on the provided data and recent market developments, here's the analysis for ABT's price movement in the next trading week:

Technical Analysis

The stock is showing strong momentum with RSI at 75.07, indicating bullish sentiment but approaching overbought territory. The MACD of 1.50 confirms positive momentum. The stock is trading above both its 20-day (114.94) and 200-day (110.26) moving averages, suggesting a strong uptrend.

News Sentiment and Fundamental Drivers

  • Abbott reported Q4 sales of $10.97 billion, slightly missing consensus of $11.01 billion
  • Analysts maintain positive outlook on Abbott's growth prospects, particularly in Diabetes Care and Structural Heart segments
  • The health care sector is expected to outperform in 2025, with medical device makers showing strong price improvements
  • Abbott's stock has gained over 10% in the first few weeks of 2025

Price Targets and Analyst Consensus

  • Average analyst price target is $139.67, with a high of $149.00 and low of $135.00
  • Recent analyst actions:
    • Wells Fargo: Overweight, $136
    • Stifel: Buy, $135
    • UBS: Buy, $148
    • Barclays: Overweight, $149

Price Prediction for Next Week Based on technical indicators and analyst sentiment:

  • Support levels: $122.18 (recent low)
  • Resistance levels: $126.66 (Fibonacci R2)
  • Expected trading range: $123.00 - $127.00

The stock is likely to continue its upward momentum but may face some resistance around $126-127 level. Traders should consider buying on dips near $123 level with a stop loss below $122.

Trading Strategy BUY with the following parameters:

  • Entry: $123.00-124.00
  • Stop Loss: $121.50
  • Take Profit: $127.00
  • Risk/Reward ratio: 1:1.5

The positive analyst sentiment, strong technical indicators, and broader healthcare sector outlook support a bullish stance for the coming week.

Based on the provided data and recent market developments, here's the analysis for ABT's price movement in the next trading week:

Technical Analysis

The stock is showing strong momentum with RSI at 75.07, indicating bullish sentiment but approaching overbought territory. The MACD of 1.50 confirms positive momentum. The stock is trading above both its 20-day (114.94) and 200-day (110.26) moving averages, suggesting a strong uptrend.

News Sentiment and Fundamental Drivers

  • Abbott reported Q4 sales of $10.97 billion, slightly missing consensus of $11.01 billion
  • Analysts maintain positive outlook on Abbott's growth prospects, particularly in Diabetes Care and Structural Heart segments
  • The health care sector is expected to outperform in 2025, with medical device makers showing strong price improvements
  • Abbott's stock has gained over 10% in the first few weeks of 2025

Price Targets and Analyst Consensus

  • Average analyst price target is $139.67, with a high of $149.00 and low of $135.00
  • Recent analyst actions:
    • Wells Fargo: Overweight, $136
    • Stifel: Buy, $135
    • UBS: Buy, $148
    • Barclays: Overweight, $149

Price Prediction for Next Week Based on technical indicators and analyst sentiment:

  • Support levels: $122.18 (recent low)
  • Resistance levels: $126.66 (Fibonacci R2)
  • Expected trading range: $123.00 - $127.00

The stock is likely to continue its upward momentum but may face some resistance around $126-127 level. Traders should consider buying on dips near $123 level with a stop loss below $122.

Trading Strategy BUY with the following parameters:

  • Entry: $123.00-124.00
  • Stop Loss: $121.50
  • Take Profit: $127.00
  • Risk/Reward ratio: 1:1.5

The positive analyst sentiment, strong technical indicators, and broader healthcare sector outlook support a bullish stance for the coming week.

ABT Similar Chart Price Prediction

The price of ABT is predicted to go up -1.02%, based on the high correlation periods with MSA. The similarity of these two price pattern on the periods is 95.94%.

stocks logo

ABT

stocks logo

MSA

Down: -1.02%Similarity: 95.94%

ABT Stock Forecast & Prediction For Years 2025, 2026, 2027, 2028, 2029 and 2030

Year

ABT Price Forecast($)

Potential Return(%)

2025

113.930

0.090

2026

135.000

18.600

2027

145.000

27.380

2028

145.000

27.380

2029

145.000

28.270

2030

160.000

41.540

What is ABT stock price prediction 2025 ?

ABT stock is currently trading at $113.93. Analysts project a price target of $132.95 for 2025, driven by expected EPS growth of 10.1% to $5.14 and strong performance in its medical devices segment. However, challenges like inflation and declining COVID testing demand may moderate gains.

What is ABT stock price prediction 2026 ?

ABT's stock price is projected to reach approximately $135 by 2026, reflecting a moderate growth trajectory. This estimate is based on its consistent EPS growth (expected to rise 10.1% in 2025), strong performance in the Medical Devices segment, and analyst consensus indicating a potential upside of 17% from current levels. However, challenges like inflation and declining COVID-related diagnostics may temper growth.

What is ABT stock price prediction 2027 ?

ABT's stock price in 2027 is projected to reach approximately $145, driven by consistent growth in its medical devices segment and strong dividend history. Analysts expect steady EPS growth, supported by innovations like FreeStyle Libre and structural heart devices. However, macroeconomic challenges and sector competition may moderate the pace of growth.

What is ABT stock price prediction 2028 ?

The price prediction for ABT stock in 2028 is estimated to be around $145. This projection is based on Abbott's consistent EPS growth, strong performance in its medical devices segment, and a historical annualized return of approximately 7-10%. However, potential risks such as inflationary pressures and foreign exchange impacts could moderate this growth.

What is ABT stock price prediction 2029 ?

ABT's stock price in 2029 is projected to reach approximately $145, driven by steady growth in its medical devices segment and consistent dividend increases. This estimate assumes a compound annual growth rate (CAGR) of 5% in earnings and a stable valuation multiple. Risks include macroeconomic factors and potential industry challenges.

What is ABT stock price prediction 2030 ?

ABT stock's price prediction for 2030 is estimated to reach $160-$180. This projection is based on Abbott's consistent growth in its medical devices and diagnostics segments, coupled with its strong dividend history and expanding global healthcare demand. However, potential risks include macroeconomic challenges and competition in the healthcare sector.

ABT Revenue Forecast

ABT EPS Forecast

ABT FAQs

What is bull’s view on ABT?

Abbott Laboratories (ABT) is viewed positively by bulls due to its strong MedTech growth and consistent earnings performance. Analysts like Barclays and UBS have raised price targets to $149 and $146, respectively, citing sustained double-digit MedTech sales growth and improved EPS guidance. With the stock currently trading around $114.76, this implies a potential upside of over 25%.

What is bear's view on ABT?

ABT stock is currently trading at $113.93, showing weakness due to industry-wide challenges like margin pressure, inflation, and declining COVID testing demand. The stock has underperformed the S&P 500, gaining only 3.3% over the past year, and its RSI of 46.38 indicates a neutral to slightly bearish momentum. With resistance at $115.50 and support at $111.93, bears may target a drop below $110 if macroeconomic pressures persist.

What is ABT revenue forecast for next quarter？

The market consensus for ABT's revenue in the upcoming quarter is projected to be approximately $10.38B USD.

What is ABT eps forecast for next quarter？

The market consensus for ABT's eps in the upcoming quarter is projected to be approximately $1.064 USD.

ABT VS S&P500

Abbott has been investing in structural heart products and recently entered the left atrial appendage closure market.

Early results from an investigational clinical trial on the Tendyne transcatheter mitral valve were favorable. If the pivotal trial results are favorable, this could give a boost to Abbott's structural heart unit.

Abbott's sale of its established pharma business in developed markets to Mylan and its acquisition of CFR and Veropharm have put the branded generics business in a strong position to benefit from growing demand in emerging markets.

Ask Intellectia about ABT

ABT Analyst's Forecast

Rick Wise

Stifel

Strong Buy

Price Target

$130 → $135

Upside

+10.54%

Stifel raised the firm's price target on Abbott to $135 from $130 and keeps a Buy rating on the shares. The firm views Abbott's Q4 results and the 2025 set-up "positively," arguing that momentum in the company's Diabetes Care business and Structural Heart business "appears primed to drive another year of double-digit Medical Device division growth" and high-single-digit total company growth, the analyst tells investors in a post-earnings note.
Danielle Antalffy

UBS

Strong Buy

Price Target

$146 → $148

Upside

+21.18%

Matt Miksic

Barclays

Buy

Price Target

$143 → $149

Upside

+26.74%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2024 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
PricingPre Market MoversFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorCopy Top Investors PortfolioCrypto Technical Analysis
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free